25 February 2022
It is recommended that quadrivalent vaccines for use in the 2022-2023 influenza season (Northern Hemisphere winter) contain the following:
Egg based vaccines:
Cell or recombinant based vaccines:
It is recommended that trivalent vaccines for use in the 2022-2023 influenza season (Northern Hemisphere winter) contain the following:
Egg based vaccines:
Cell or recombinant based vaccines:
7 October 2021
The AIVC met on 6 October 2021 and recommended that the following viruses be used for influenza vaccines in the 2022 Southern Hemisphere influenza season:
Egg based vaccines:
Cell or recombinant based vaccines:
The composition of trivalent influenza vaccines is recommended to include the H1N1, H3N2 and the B Victoria lineage virus.
See the TGA website for further information
24 September 2021
It is recommended that quadrivalent vaccines for use in the 2022 influenza season (Southern Hemisphere winter) contain the following:
Egg based vaccines:
Cell or recombinant based vaccines:
It is recommended that trivalent vaccines for use in the 2022 influenza season (Southern Hemisphere winter) contain the following:
Egg based vaccines:
Cell or recombinant based vaccines:
26 February 2021
It is recommended that quadrivalent vaccines for use in the 2021-2022 influenza season (Northern Hemisphere winter) contain the following:
Egg based vaccines:
Cell or recombinant based vaccines:
It is recommended that trivalent vaccines for use in the 2021-2022 influenza season (Northern Hemisphere winter) contain the following:
Egg based vaccines:
Cell or recombinant based vaccines:
9 October 2020
The AIVC met on 7 October 2020 and recommended that the following viruses be used for influenza vaccines in the 2021 Southern Hemisphere influenza season:
Egg based vaccines:
Cell or recombinant based vaccines:
See the TGA website for further information
25 September 2020
It is recommended that quadrivalent vaccines for use in the 2021 influenza season (Southern Hemisphere winter) contain the following:
Egg based vaccines:
Cell or recombinant based vaccines:
It is recommended that trivalent vaccines for use in the 2021 influenza season (Southern Hemisphere winter) contain the following:
Egg based vaccines:
Cell or recombinant based vaccines:
3 March 2020
It is recommended that quadrivalent vaccines for use in the 2020-2021 influenza season (Northern Hemisphere winter) contain the following:
Egg based vaccines:
Cell or recombinant based vaccines:
It is recommended that trivalent vaccines for use in the 2020-2021 influenza season (Northern Hemisphere winter) contain the following:
Egg based vaccines:
Cell or recombinant based vaccines:
23 October 2019
The AIVC met on 9 October 2019 and recommended that the following viruses be used for influenza vaccines in the 2020 Southern Hemisphere influenza season:
Egg based quadrivalent vaccines:
Egg based trivalent vaccines:
See the TGA website for further information
1 October 2019
It is recommended that quadrivalent vaccines for use in the 2020 influenza season (Southern Hemisphere winter) contain the following:
Egg based vaccines:
It is recommended that trivalent vaccines for use in the 2020 influenza season (Southern Hemisphere winter) contain the following:
Egg based vaccines: